1. Home
  2. XYLO vs SCNI Comparison

XYLO vs SCNI Comparison

Compare XYLO & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYLO
  • SCNI
  • Stock Information
  • Founded
  • XYLO 1999
  • SCNI 2003
  • Country
  • XYLO Israel
  • SCNI Israel
  • Employees
  • XYLO N/A
  • SCNI N/A
  • Industry
  • XYLO
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • XYLO
  • SCNI Health Care
  • Exchange
  • XYLO NYSE
  • SCNI Nasdaq
  • Market Cap
  • XYLO 3.1M
  • SCNI 2.8M
  • IPO Year
  • XYLO N/A
  • SCNI N/A
  • Fundamental
  • Price
  • XYLO $3.81
  • SCNI $3.52
  • Analyst Decision
  • XYLO
  • SCNI
  • Analyst Count
  • XYLO 0
  • SCNI 0
  • Target Price
  • XYLO N/A
  • SCNI N/A
  • AVG Volume (30 Days)
  • XYLO 9.8K
  • SCNI 20.5K
  • Earning Date
  • XYLO 09-20-2024
  • SCNI 11-22-2024
  • Dividend Yield
  • XYLO N/A
  • SCNI N/A
  • EPS Growth
  • XYLO N/A
  • SCNI N/A
  • EPS
  • XYLO N/A
  • SCNI 8.20
  • Revenue
  • XYLO $57,642,000.00
  • SCNI $452,000.00
  • Revenue This Year
  • XYLO $16.76
  • SCNI N/A
  • Revenue Next Year
  • XYLO $5.71
  • SCNI N/A
  • P/E Ratio
  • XYLO N/A
  • SCNI $0.43
  • Revenue Growth
  • XYLO N/A
  • SCNI N/A
  • 52 Week Low
  • XYLO $2.70
  • SCNI $2.23
  • 52 Week High
  • XYLO $8.83
  • SCNI $8.92
  • Technical
  • Relative Strength Index (RSI)
  • XYLO 39.04
  • SCNI 52.91
  • Support Level
  • XYLO $4.08
  • SCNI $3.30
  • Resistance Level
  • XYLO $5.33
  • SCNI $3.60
  • Average True Range (ATR)
  • XYLO 0.49
  • SCNI 0.25
  • MACD
  • XYLO -0.09
  • SCNI -0.01
  • Stochastic Oscillator
  • XYLO 0.00
  • SCNI 44.05

About XYLO XYLO TECHNOLOGIES LTD

Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

Share on Social Networks: